Please login to the form below

bipolar disorder

This page shows the latest bipolar disorder news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Italy in turmoil, Pharma attacks Europe's generics move and more

Its pipeline includes Risperidone Extended-Release Microspheres for Injection candidate (LY03004) for schizophrenia and bipolar disorder, and plans to launch in China and the US by the end of 2018, while

Latest news

First digital medicine approved in the US

Abilify MyCite is the latest iteration of antipsychotic blockbuster Abilify (aripiprazole) to reach the market, and is approved for the same indications as its parent products - schizophrenia, bipolar I disorder and
Lundbeck and Otsuka start phase III for Rexulti in bipolar

Lundbeck and Otsuka start phase III for Rexulti in bipolar. Drug is also in phase II trial to treat PTSD patients. ... Otsuka and co-development partner Lundbeck have started two phase III trials of their atypical antipsychotic Rexulti in bipolar disorder
Lundbeck partners with 23andMe on first-of-its-kind study

The US project will involve 25, 000 patients and combine data from genetics, cognitive tests and online surveys to explore how genetics is related to major depressive disorder (MDD), bipolar depression ... Anders Gersel Pedersen, executive VP, research
Otsuka refiles 'digital' medicine for mental illness

Abilify is approved to treat schizophrenia, bipolar disorder and major depressive disorder.
FDA knocks-back Otsuka's digital pill plans

Otsuka had submitted the device for approval to measure medication adherence to Abilify (aripiprazole) in patients with schizophrenia, as an acute treatment of manic and mixed episodes associated with bipolar I ... disorder and as an adjunctive treatment

More from news
Approximately 7 fully matching, plus 85 partially matching documents found.

Latest Intelligence

Drug pricing in Ireland

As such, patients with coronary syndromes, multiple sclerosis, bipolar disorder and Hepatitis C were being denied access to effective treatments, while treatments for other diseases were also subject to restrictions.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

there’ s an abundance of smart thinking on how to improve the lives of people who struggle with major depression, schizophrenia, bipolar disorder, and other serious conditions.
How health behaviours and clinical outcomes are related

Patients suffering from post-traumatic stress disorder, schizophrenia, bipolar disorder and depression also have more positive outcomes with higher patient activation levels.
AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

there’ s an abundance of smart thinking on how to improve the lives of people who struggle with major depression, schizophrenia, bipolar disorder, and other serious conditions.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Account Director or Senior Account Director: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Market Access Consultant - Greater Manchester: Negotiable

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Medical Writer - Creative and Scientific Projects: DOE

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Senior Training Manager - Surrey: Competitive Salary &Bonus

Associate Scientific Director: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Writer, Healthcare Advertising, London: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Systematic Review Lead- London: Negotiable

Sudler London - Senior Medical Writer: Competitive

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Medical Writer: Salary is DOE

Account Manager- 4 days per week or full-time: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Subscribe to our email news alerts

PMHub

Add my company

Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....